- Investing Ideas
- /
- Hong Kong Healthcare Global Supply Chain Shortage
Hong Kong Healthcare Global Supply Chain Shortage
Results
20
20 companies
Sinopharm Group
Market Cap: HK$63.7b
Engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China.
1099
HK$20.40
7D
-4.4%
1Y
-4.2%
160 Health International
Market Cap: HK$17.7b
160 Health International Limited wholesales and retails pharmaceutical and healthcare products in China.
2656
HK$52.55
7D
8.6%
1Y
n/a
IVD Medical Holding
Market Cap: HK$9.5b
An investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally.
1931
HK$5.88
7D
-12.5%
1Y
230.3%
YSB
Market Cap: HK$4.9b
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
9885
HK$7.21
7D
-11.8%
1Y
13.9%
Shanghai Pioneer Holding
Market Cap: HK$2.3b
An investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People’s Republic of China.
1345
HK$1.95
7D
-4.4%
1Y
-4.9%
China Health Group
Market Cap: HK$897.2m
An investment holding company, engages in the distribution and services of medical equipment and consumables in the People’s Republic of China.
673
HK$0.67
7D
-2.9%
1Y
9.8%
Charmacy Pharmaceutical
Market Cap: HK$761.4m
Engages in the pharmaceutical distribution business in the People’s Republic of China.
2289
HK$7.05
7D
23.0%
1Y
-25.8%
ClouDr Group
Market Cap: HK$729.7m
Provides supplies and software as a service (SaaS) installation to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management.
9955
HK$1.13
7D
-5.0%
1Y
-12.4%
Guanze Medical Information Industry (Holding)
Market Cap: HK$570.0m
An investment holding company, provides medical imaging solutions in the People’s Republic of China.
2427
HK$0.60
7D
15.4%
1Y
39.5%
Sinco Pharmaceuticals Holdings
Market Cap: HK$406.6m
An investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China.
6833
HK$0.20
7D
0.5%
1Y
9.9%
Kingworld Medicines Group
Market Cap: HK$300.7m
An investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products.
1110
HK$0.51
7D
-1.9%
1Y
14.6%
Yunnan Energy International
Market Cap: HK$269.9m
An investment holding company, distributes analytical and laboratory instruments, and life science equipment in the People’s Republic of China, rest of Asia, and internationally.
1298
HK$0.98
7D
0%
1Y
28.9%
Tycoon Group Holdings
Market Cap: HK$241.4m
An investment holding company, distributes and retails a suite of health and well-being related products in Mainland China, Hong Kong, Macau, Singapore, Malaysia, and internationally.
3390
HK$0.27
7D
-5.3%
1Y
-92.4%
Sinopharm Tech Holdings
Market Cap: HK$218.6m
An investment holding company, engages in trading of medical and related products in China.
8156
HK$0.34
7D
3.0%
1Y
n/a
Universal Health International Group Holding
Market Cap: HK$212.2m
An investment holding company, distributes and retails drugs and other pharmaceutical products in the northeastern region of the People’s Republic of China.
2211
HK$1.92
7D
-0.5%
1Y
56.1%
Tai United Holdings
Market Cap: HK$152.3m
An investment holding company, primarily invests in properties in the People’s Republic of China, the United States, the United Kingdom, Australia, and Belgium.
718
HK$0.029
7D
-21.6%
1Y
-37.0%
Grand Brilliance Group Holdings
Market Cap: HK$91.2m
An investment holding company, engages in supplying of medical devices in Hong Kong.
8372
HK$0.11
7D
0%
1Y
22.6%
Wanjia Group Holdings
Market Cap: HK$84.0m
An investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong.
401
HK$0.15
7D
-1.3%
1Y
105.5%
Pa Shun International Holdings
Market Cap: HK$73.7m
An investment holding company, engages in the pharmaceutical distribution and manufacturing businesses in the People’s Republic of China.
574
HK$0.05
7D
2.0%
1Y
2.0%
New Ray Medicine International Holding
Market Cap: HK$49.3m
An investment holding company, engages in distribution and trading of pharmaceutical and related products in the People’s Republic of China.
6108
HK$0.29
7D
-7.8%
1Y
-38.5%